Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Tandem Diabetes Care stock | 95.75

Own Tandem Diabetes Care stock in just a few minutes.


Fact checked

Tandem Diabetes Care, Inc is a medical devices business based in the US. Tandem Diabetes Care shares (TNDM) are listed on the NASDAQ and all prices are listed in US Dollars. Tandem Diabetes Care employs 1,043 staff and has a trailing 12-month revenue of around USD$439.2 million.

How to buy shares in Tandem Diabetes Care

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Tandem Diabetes Care. Find the stock by name or ticker symbol: TNDM. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tandem Diabetes Care reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$95.75, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Tandem Diabetes Care, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Tandem Diabetes Care. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Tandem Diabetes Care's share price?

Since the stock market crash in March caused by coronavirus, Tandem Diabetes Care's share price has had significant positive movement.

Its last market close was USD$95.75, which is 8.09% up on its pre-crash value of USD$88 and 119.16% up on the lowest point reached during the March crash when the shares fell as low as USD$43.69.

If you had bought USD$1,000 worth of Tandem Diabetes Care shares at the start of February 2020, those shares would have been worth USD$692.74 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,261.99.

Tandem Diabetes Care share price

Use our graph to track the performance of TNDM stocks over time.

Tandem Diabetes Care shares at a glance

Information last updated 2020-11-24.
Latest market close USD$95.75
52-week range USD$43.69 - USD$123.74
50-day moving average USD$110.1642
200-day moving average USD$101.1444
Wall St. target price USD$129.13
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.96

Buy Tandem Diabetes Care shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tandem Diabetes Care stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tandem Diabetes Care price performance over time

Historical closes compared with the close of $95.75 from 2020-11-16

1 week (2020-11-16) N/A
1 month (2020-10-23) N/A
3 months (2020-08-23) N/A
6 months (2020-05-23) N/A
1 year (2019-11-23) N/A
2 years (2018-11-23) N/A
3 years (2017-11-23) N/A
5 years (2015-11-23) N/A

Tandem Diabetes Care financials

Revenue TTM USD$439.2 million
Gross profit TTM USD$194.2 million
Return on assets TTM -3.17%
Return on equity TTM -19.75%
Profit margin -11.1%
Book value $5.257
Market capitalisation USD$5.8 billion

TTM: trailing 12 months

Shorting Tandem Diabetes Care shares

There are currently 2.8 million Tandem Diabetes Care shares held short by investors – that's known as Tandem Diabetes Care's "short interest". This figure is 2.8% down from 2.9 million last month.

There are a few different ways that this level of interest in shorting Tandem Diabetes Care shares can be evaluated.

Tandem Diabetes Care's "short interest ratio" (SIR)

Tandem Diabetes Care's "short interest ratio" (SIR) is the quantity of Tandem Diabetes Care shares currently shorted divided by the average quantity of Tandem Diabetes Care shares traded daily (recently around 586311.43451143). Tandem Diabetes Care's SIR currently stands at 4.81. In other words for every 100,000 Tandem Diabetes Care shares traded daily on the market, roughly 4810 shares are currently held short.

However Tandem Diabetes Care's short interest can also be evaluated against the total number of Tandem Diabetes Care shares, or, against the total number of tradable Tandem Diabetes Care shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tandem Diabetes Care's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Tandem Diabetes Care shares in existence, roughly 50 shares are currently held short) or 0.0519% of the tradable shares (for every 100,000 tradable Tandem Diabetes Care shares, roughly 52 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tandem Diabetes Care.

Find out more about how you can short Tandem Diabetes Care stock.

Tandem Diabetes Care share dividends

We're not expecting Tandem Diabetes Care to pay a dividend over the next 12 months.

Have Tandem Diabetes Care's shares ever split?

Tandem Diabetes Care's shares were split on a 1:10 basis on 10 October 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tandem Diabetes Care shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Tandem Diabetes Care shares which in turn could have impacted Tandem Diabetes Care's share price.

Tandem Diabetes Care share price volatility

Over the last 12 months, Tandem Diabetes Care's shares have ranged in value from as little as $43.69 up to $123.74. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tandem Diabetes Care's is 0.4741. This would suggest that Tandem Diabetes Care's shares are less volatile than average (for this exchange).

Tandem Diabetes Care overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin delivery system with Basal-IQ Technology; t:slim X2 with control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Further, the company offers Sugarmate, a mobile app for people with diabetes who use insulin. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site